Cargando…

The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy

OBJECTIVE: Chagas' disease has spread throughout Latin America because of the high rate of migration among these countries. Approximately 30% of Chagas' patients will develop cardiomyopathy, and 10% of these will develop severe cardiac damage leading to heart failure. Beta-blockade improve...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Souza Pimentel, Walace, Ramires, Felix José Alvarez, Ianni, Barbara Maria, Salemi, Vera Maria Cury, Bilate, Angelina Morand Bianchi, Cunha-Neto, Edécio, de Oliveira, Adriana Morgan, Fernandes, Fábio, Mady, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012
Materias:	Basic Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438248/ https://www.ncbi.nlm.nih.gov/pubmed/23018305 http://dx.doi.org/10.6061/clinics/2012(09)14

Ejemplares similares

Selective Decrease of Components of the Creatine Kinase System and ATP Synthase Complex in Chronic Chagas Disease Cardiomyopathy
por: Teixeira, Priscila Camillo, et al.
Publicado: (2011)

Chagas Disease Cardiomyopathy: Immunopathology and Genetics
por: Cunha-Neto, Edecio, et al.
Publicado: (2014)

Genome Wide Association Study (GWAS) of Chagas Cardiomyopathy in Trypanosoma cruzi Seropositive Subjects
por: Deng, Xutao, et al.
Publicado: (2013)

Air Pollution’s Impact on Cardiac Remodeling in an Experimental Model of Chagas Cardiomyopathy
por: Fonseca, Keila Cardoso Barbosa, et al.
Publicado: (2022)

Dysregulation of Autonomic Nervous System in Chagas’ Heart Disease Is Associated with Altered Adipocytokines Levels
por: Barbosa-Ferreira, João Marcos, et al.
Publicado: (2015)

Evidence for T Cell Help in the IgG Response against Tandemly Repetitive Trypanosoma cruzi B13 Protein in Chronic Chagas Disease Patients
por: Duranti, Marcia, et al.
Publicado: (2012)

Myocardial Chemokine Expression and Intensity of Myocarditis in Chagas Cardiomyopathy Are Controlled by Polymorphisms in CXCL9 and CXCL10
por: Nogueira, Luciana Gabriel, et al.
Publicado: (2012)

Galectina-3 Associada a Formas Graves e Mortalidade em Longo Prazo em Pacientes com Doença de Chagas
por: Fernandes, Fábio, et al.
Publicado: (2021)

Left Atrial Function in Patients with Chronic Chagasic Cardiomyopathy
por: Fragata, Claudia da Silva, et al.
Publicado: (2015)

Blood DNA methylation marks discriminate Chagas cardiomyopathy disease clinical forms
por: Brochet, Pauline, et al.
Publicado: (2022)

Polymorphisms in Genes Affecting Interferon-γ Production and Th1 T Cell Differentiation Are Associated With Progression to Chagas Disease Cardiomyopathy
por: Frade-Barros, Amanda Farage, et al.
Publicado: (2020)

Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways
por: Frade, Amanda Farage, et al.
Publicado: (2013)

Histopathological Correlates of Global and Segmental Left Ventricular Systolic Dysfunction in Experimental Chronic Chagas Cardiomyopathy
por: de Oliveira, Luciano Fonseca Lemos, et al.
Publicado: (2016)

Corrigendum: Polymorphisms in Genes Affecting Interferon-γ Production and Th1 T Cell Differentiation Are Associated With Progression to Chagas Disease Cardiomyopathy
por: Farage Frade-Barros, Amanda, et al.
Publicado: (2020)

New Biomarker in Chagas Disease: Extracellular Vesicles Isolated from Peripheral Blood in Chronic Chagas Disease Patients Modulate the Human Immune Response
por: Madeira, Rafael Pedro, et al.
Publicado: (2021)

Rare Pathogenic Variants in Mitochondrial and Inflammation-Associated Genes May Lead to Inflammatory Cardiomyopathy in Chagas Disease
por: Ouarhache, Maryem, et al.
Publicado: (2021)

Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy
por: Chevillard, Christophe, et al.
Publicado: (2018)

Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy
por: Nonaka, Carolina Kymie Vasques, et al.
Publicado: (2019)

Treatment of Chagas Cardiomyopathy
por: Botoni, Fernando A., et al.
Publicado: (2013)

Chronic Chagas cardiomyopathy
por: Aiello, Vera Demarchi, et al.
Publicado: (2015)

Losartan Reduces Remodeling and Apoptosis in an Adriamycin-Induced Cardiomyopathy Rat Model
por: Kim, Hyeon A, et al.
Publicado: (2023)

Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile
por: Cardoso, Clareci Silva, et al.
Publicado: (2016)

Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
por: Teixeira, Priscila Camillo, et al.
Publicado: (2021)

Biomakers in Chronic Chagas Cardiomyopathy
por: Rodrigues, Angela Braga, et al.
Publicado: (2022)

Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance
por: Torreão, Jorge A., et al.
Publicado: (2015)

Epigenetic regulation of transcription factor binding motifs promotes Th1 response in Chagas disease cardiomyopathy
por: Brochet, Pauline, et al.
Publicado: (2022)

Noncompaction cardiomyopathy: a substrate for a thromboembolic event
por: Tavares de Melo, Marcelo Dantas, et al.
Publicado: (2015)

Exercise training prevents diastolic dysfunction induced by metabolic syndrome in rats
por: Mostarda, Cristiano, et al.
Publicado: (2012)

The role of air pollution in myocardial remodeling
por: de Oliveira-Fonoff, A. M., et al.
Publicado: (2017)

Chagas’ heart disease: gender differences in myocardial damage assessed by cardiovascular magnetic resonance
por: Assunção, Antonildes N., et al.
Publicado: (2016)

Echocardiographic and hemodynamic determinants of right coronary artery flow reserve and phasic flow pattern in advanced non-ischemic cardiomyopathy
por: Graziosi, Pedro, et al.
Publicado: (2007)

Parasitic Load Correlates With Left Ventricular Dysfunction in Patients With Chronic Chagas Cardiomyopathy
por: de Oliveira, Maykon Tavares, et al.
Publicado: (2021)

Imaging Diagnosis of Right Ventricle Involvement in Chagas Cardiomyopathy
por: Romano, Minna M. D., et al.
Publicado: (2017)

Menor Prevalência e Extensão da Aterosclerose Coronária na Doença de Chagas Crônica por Angiotomografia Coronária
por: Cardoso, Savio, et al.
Publicado: (2020)

Clinical Presentations of Chagas Cardiomyopathy
por: Shehadeh, Malik, et al.
Publicado: (2020)

Matrix Metalloproteinase 2 and 9 Enzymatic Activities are Selectively Increased in the Myocardium of Chronic Chagas Disease Cardiomyopathy Patients: Role of TIMPs
por: Baron, Monique Andrade, et al.
Publicado: (2022)

Myocardial Gene Expression of T-bet, GATA-3, Ror-γt, FoxP3, and Hallmark Cytokines in Chronic Chagas Disease Cardiomyopathy: An Essentially Unopposed T(H)1-Type Response
por: Nogueira, Luciana Gabriel, et al.
Publicado: (2014)

Does left ventricular reverse remodeling influence long-term outcomes in patients with Chagas cardiomyopathy?
por: Nakazone, Marcelo Arruda, et al.
Publicado: (2022)

Prevalence of Chagas heart disease in dilated cardiomyopathy
por: González-Zambrano, Héctor, et al.
Publicado: (2021)

Chagas Cardiomyopathy Manifestations and Trypanosoma cruzi Genotypes Circulating in Chronic Chagasic Patients
por: Ramírez, Juan David, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_urld0klm8n85tct62ck3hsj91k